Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

22 March 2022

Jayasree K. Iyer in Der Tagesspiegel: 'Fehlender Zugang zu Insulin'

Access to Medicine Foundation CEO Jayasree K. Iyer's Project Syndicate op-ed "Insulin Belongs to the World" has appeared in translation in Der Tagesspiegel, a Germany daily newspaper.

The article, headlined "Fehlender Zugang zu Insulin: Zu viele Patienten müssen unnötig leiden," lays out current issues in access to insulin, and some of the key challenges ahead. 

Jayasree argues that governments and pharmaceutical companies must do their part to increase access to insulin in low- and middle-income countries – including not just older forms of human insulin, but also the innovative analog insulins which are increasingly becoming the preferred choice of both diabetes patients and doctors. To reach this goal, chronic problems in the insulin market must be addressed.

Project Syndicate, known as "the world's opinion page", is an international media organisation that publishes commentary and analysis on a variety of important topics, and also syndicates these opinion pieces to publications around the world.

The op-ed has so far been syndicated to publications in countries including Lebanon, Sri Lanka, and Jordan, and has been published in languages including English, French and German.

Read the full article in German in Der Tagesspiegel.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved